Photodynamic therapy (PDT), which combines light sources with light-activated drugs known
as photosensitizers (PSs), has garnered significant attention as a potential therapeutic …

As we all know, cancer is still a disease that we are struggling against. Although the
traditional treatment options are still the mainstream in clinical practice, emerging …

Photodynamic therapy (PDT) has been considered to become a promising tumor treatment
method due to its non-invasiveness and low-risk. However, there are two factors that will …

Abstract Two-dimensional (2D) metal-organic frameworks (MOFs) have emerged as
promising photosensitizers in photodynamic therapy in recent years. In comparison to bulk …

Conventional photosensitizers for tumor phototherapy are greatly limited by their reliance on
a single‐cell death process, leading to insufficient therapeutic effects and restricted …

Biomacromolecules play a critical role in advancing disease diagnosis and treatment.
Traditional carriers often lack real-time tracking capabilities, controlled drug release, and …

Supramolecular assemblies based on the twisted donor–acceptor–donor (DAD) building
block Qx-Ind have been developed, which interestingly, due to the balanced angle of twist …

The rapid rise of antibiotic-resistant strains and the persistence of biofilm-associated
infections have significantly challenged global public health. Unfortunately, current clinical …

Type‐I photosensitizers (PSs) are among the most potential candidates for photodynamic
therapy (PDT), as their low dependence on oxygen endow them with many advantages for …

Photodynamic therapy (PDT), a minimally invasive and effective local treatment, heavily
depends on photosensitizer (PS) performance and oxygen availability. Despite the use of …